Form 4: Bristol-Myers Squibb Executive Samit Hirawat Acquires 4,250 Shares

Samit Hirawat, EVP, Chief Medical Officer, Drug Development at Bristol-Myers Squibb, purchased 4,250 shares of BMY stock at $47.58 per share on April 25, 2025.

Summary

• On April 25, 2025, Samit Hirawat, an executive at Bristol-Myers Squibb, acquired 4,250 shares of the company's common stock.
• The purchase price was $47.58 per share.
• Following the transaction, Hirawat directly owns 83,513.486 shares of Bristol-Myers Squibb.
• The transaction was reported on April 29, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects an insider purchase, which can be seen as a positive signal, but without further context, it's difficult to gauge the overall impact.

Positives

• The purchase of shares by an executive could be interpreted as a positive signal about the executive's confidence in the company's future prospects.

Industry Context

Insider trading activity is closely monitored by regulators and investors as it can provide insights into the perspectives of company executives on the company's performance and prospects. Purchases are generally seen as a positive sign.

Stakeholder Impact

• The purchase of shares by an executive could increase investor confidence.

Key Dates

Keywords

Form 4, insider trading, stock purchase, Samit Hirawat, Bristol-Myers Squibb, BMY, executive, shares